News and Announcements
Shivom Will be Featured on an Episode of Advancement Series
- Published June 19, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Shivom will be featured on an episode of Advancement series
- The series is an Infotainment show that covers innovative and educational projects
- The episode will be anchored by Ted Danson
Shivom are so excited to share that their project will be featured on an episode of Advancement Series, a brainchild of DMG Productions.
The series is an Infotainment show that covers innovative and educational projects that are pathbreaking and revolutionary in their undertakings. Shivom was selected for its unprecedented use of convergent technologies and goal of creating the larger genomic data hub on the planet and its projected contribution to Precision Medicine.
Th episode will cover the platform that Shivom lays down for non-profit research and development is the field of genomics and open collaboration and solutions for genetic research.
The episode will be anchored by Ted Danson and is scheduled to be broadcasted in the 4th OTR of this year.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
